https://www.selleckchem.com/pr....oducts/pf-4708671.ht
etric properties, and its sensitivity to detect symptom changes after treatment ensure NSS-P future use in clinical and research settings. We validated a brief instrument to assess NT1 symptom frequency, severity and consequences in ≥10-year-old children and adolescents, with four clinically relevant severity score ranges. This scale constitutes a relevant tool to improve and provide guidance for NT1 management in pediatric populations. The ease of administration, its good psychometric properties, and its sensitivity to detect sympto
Mi piace
Commento
Condividi
